Finerenone in Type 1 Diabetes and Chronic Kidney Disease
In adults with type 1 diabetes and CKD, finerenone results in a significantly greater decrease in the urinary albumin-to-creatinine ratio than placebo.
- True
- False
In adults with type 1 diabetes and CKD, finerenone results in a significantly greater decrease in the urinary albumin-to-creatinine ratio than placebo.
In patients with chronic kidney disease (CKD), which one of the following statements about the impact of the treatment of hypertension and cardiovascular risk reduction is false?
Among patients receiving inpatient rehabilitation for acute stroke, levodopa added to standardized rehabilitation significantly improves function at 3 months compared with placebo plus standardized rehabilitation.
Canagliflozin is associated with improved cardiovascular mortality in frail patients with Type 2 Diabetes Mellitus.
In adult patients with subclinical hypothyroidism with a thyrotropin level between 5 mIU/L and 10 mIU/L, levothyroxine treatment was associated with a reduced risk of adverse renal outcomes when compared with no treatment.
A strategy using the combined measurement of the biomarkers glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase-L1 (UCH-L1) has 100% sensitivity and 100% negative predictive value for ruling out intracranial injury in patients with mild traumatic brain injury.
Use of depot medroxyprogesterone acetate is associated with a greater relative risk of meningioma diagnosis.
Immigrants to Canada are more likely to develop incident adverse kidney outcomes compared to non-immigrants.
Which one of the following statements regarding the use of Factor Xa inhibitors, as compared to vitamin K antagonists, in atrial fibrillation patients on dialysis is false?
Candesartan is effective for prevention of episodic and chronic migraines.
The use of Sodium Glucose cotransporter-2 inhibitors in patients with Systemic Lupus Erythematosus and Type 2 Diabetes is associated with reduction in the risk of Lupus nephritis.
A 5-day treatment of acute febrile UTIs in children with oral amoxicillin-clavulanic acid was non-inferior to a 10-day treatment.
In patients with chronic kidney disease, type 2 diabetes, and hypertension (the kidney-dysfunction triad) the use of an EHR-based algorithm and practice facilitators embedded in primary care to assist providers in delivering guideline-based interventions reduces hospitalization rate at 1 year.
In patients with chronic kidney disease empagliflozin reduces the risk of kidney disease progression.